GO:0044281 | small molecule metabolic process | 8.72% (13/149) | 3.96 | 0.0 | 0.0 |
GO:0009987 | cellular process | 23.49% (35/149) | 1.36 | 0.0 | 2.6e-05 |
GO:0008150 | biological_process | 31.54% (47/149) | 1.02 | 1e-06 | 8.6e-05 |
GO:0003674 | molecular_function | 39.6% (59/149) | 0.84 | 1e-06 | 9.5e-05 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.68% (4/149) | 4.12 | 6.1e-05 | 0.002311 |
GO:0019752 | carboxylic acid metabolic process | 3.36% (5/149) | 3.61 | 4.5e-05 | 0.002349 |
GO:0006082 | organic acid metabolic process | 3.36% (5/149) | 3.61 | 4.5e-05 | 0.002349 |
GO:0043436 | oxoacid metabolic process | 3.36% (5/149) | 3.61 | 4.5e-05 | 0.002349 |
GO:0009056 | catabolic process | 4.03% (6/149) | 3.12 | 5.7e-05 | 0.002356 |
GO:1901564 | organonitrogen compound metabolic process | 10.74% (16/149) | 1.58 | 8.7e-05 | 0.002591 |
GO:0044237 | cellular metabolic process | 14.77% (22/149) | 1.33 | 5.6e-05 | 0.002592 |
GO:0043605 | cellular amide catabolic process | 2.01% (3/149) | 4.93 | 8.3e-05 | 0.002664 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.68% (4/149) | 4.02 | 8.2e-05 | 0.002852 |
GO:1901575 | organic substance catabolic process | 4.03% (6/149) | 3.23 | 3.7e-05 | 0.003052 |
GO:0019637 | organophosphate metabolic process | 3.36% (5/149) | 3.34 | 0.000114 | 0.003145 |
GO:0006520 | cellular amino acid metabolic process | 2.68% (4/149) | 3.61 | 0.000275 | 0.003561 |
GO:0030833 | regulation of actin filament polymerization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0090066 | regulation of anatomical structure size | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0110053 | regulation of actin filament organization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0032271 | regulation of protein polymerization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0044087 | regulation of cellular component biogenesis | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0032535 | regulation of cellular component size | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0043254 | regulation of protein-containing complex assembly | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0032970 | regulation of actin filament-based process | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0030832 | regulation of actin filament length | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0051493 | regulation of cytoskeleton organization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:1902903 | regulation of supramolecular fiber organization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.34% (2/149) | 5.93 | 0.000267 | 0.003579 |
GO:1901565 | organonitrogen compound catabolic process | 2.01% (3/149) | 4.71 | 0.000144 | 0.003743 |
GO:1901360 | organic cyclic compound metabolic process | 7.38% (11/149) | 1.8 | 0.000308 | 0.003875 |
GO:0008152 | metabolic process | 21.48% (32/149) | 0.94 | 0.000188 | 0.004591 |
GO:0009117 | nucleotide metabolic process | 2.01% (3/149) | 4.51 | 0.000228 | 0.005259 |
GO:0006753 | nucleoside phosphate metabolic process | 2.01% (3/149) | 4.19 | 0.000477 | 0.005823 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.03% (6/149) | 2.56 | 0.000508 | 0.006027 |
GO:0071704 | organic substance metabolic process | 14.77% (22/149) | 1.04 | 0.000915 | 0.009732 |
GO:0017144 | drug metabolic process | 2.01% (3/149) | 3.93 | 0.000854 | 0.009843 |
GO:0046483 | heterocycle metabolic process | 6.71% (10/149) | 1.72 | 0.000911 | 0.009948 |
GO:0006807 | nitrogen compound metabolic process | 12.08% (18/149) | 1.18 | 0.000907 | 0.010174 |
GO:1901361 | organic cyclic compound catabolic process | 2.01% (3/149) | 3.81 | 0.001097 | 0.0111 |
GO:0046700 | heterocycle catabolic process | 2.01% (3/149) | 3.81 | 0.001097 | 0.0111 |
GO:0000255 | allantoin metabolic process | 1.34% (2/149) | 4.93 | 0.00157 | 0.01416 |
GO:0044282 | small molecule catabolic process | 1.34% (2/149) | 4.93 | 0.00157 | 0.01416 |
GO:0000256 | allantoin catabolic process | 1.34% (2/149) | 4.93 | 0.00157 | 0.01416 |
GO:0033043 | regulation of organelle organization | 1.34% (2/149) | 4.93 | 0.00157 | 0.01416 |
GO:0003824 | catalytic activity | 20.13% (30/149) | 0.8 | 0.001516 | 0.014981 |
GO:0016829 | lyase activity | 2.68% (4/149) | 2.93 | 0.00175 | 0.015448 |
GO:0019438 | aromatic compound biosynthetic process | 3.36% (5/149) | 2.47 | 0.001997 | 0.01727 |
GO:0019318 | hexose metabolic process | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0042737 | drug catabolic process | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0009259 | ribonucleotide metabolic process | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0019693 | ribose phosphate metabolic process | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0009150 | purine ribonucleotide metabolic process | 1.34% (2/149) | 4.61 | 0.002588 | 0.019526 |
GO:0044248 | cellular catabolic process | 2.68% (4/149) | 2.76 | 0.002724 | 0.020188 |
GO:0006725 | cellular aromatic compound metabolic process | 6.04% (9/149) | 1.6 | 0.002899 | 0.021108 |
GO:0018130 | heterocycle biosynthetic process | 3.36% (5/149) | 2.39 | 0.00253 | 0.021425 |
GO:0044283 | small molecule biosynthetic process | 2.01% (3/149) | 3.27 | 0.003457 | 0.024736 |
GO:0006163 | purine nucleotide metabolic process | 1.34% (2/149) | 4.34 | 0.00384 | 0.025702 |
GO:1901615 | organic hydroxy compound metabolic process | 1.34% (2/149) | 4.34 | 0.00384 | 0.025702 |
GO:0051128 | regulation of cellular component organization | 1.34% (2/149) | 4.34 | 0.00384 | 0.025702 |
GO:0005996 | monosaccharide metabolic process | 1.34% (2/149) | 4.34 | 0.00384 | 0.025702 |
GO:0043038 | amino acid activation | 1.34% (2/149) | 4.12 | 0.005318 | 0.03294 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.34% (2/149) | 4.12 | 0.005318 | 0.03294 |
GO:0043039 | tRNA aminoacylation | 1.34% (2/149) | 4.12 | 0.005318 | 0.03294 |
GO:0072521 | purine-containing compound metabolic process | 1.34% (2/149) | 4.12 | 0.005318 | 0.03294 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.34% (2/149) | 4.12 | 0.005318 | 0.03294 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 4.7% (7/149) | 1.71 | 0.005468 | 0.033372 |
GO:0046434 | organophosphate catabolic process | 1.34% (2/149) | 3.93 | 0.007015 | 0.04219 |
GO:0003725 | double-stranded RNA binding | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:1901879 | regulation of protein depolymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0072524 | pyridine-containing compound metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046184 | aldehyde biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0043242 | negative regulation of protein-containing complex disassembly | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006012 | galactose metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0072525 | pyridine-containing compound biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0042816 | vitamin B6 metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0042822 | pyridoxal phosphate metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0042819 | vitamin B6 biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0042274 | ribosomal small subunit biogenesis | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0032272 | negative regulation of protein polymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0030835 | negative regulation of actin filament depolymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0043087 | regulation of GTPase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051016 | barbed-end actin filament capping | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0031333 | negative regulation of protein-containing complex assembly | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051129 | negative regulation of cellular component organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0030834 | regulation of actin filament depolymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051494 | negative regulation of cytoskeleton organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051693 | actin filament capping | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051336 | regulation of hydrolase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:1901880 | negative regulation of protein depolymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0004359 | glutaminase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:1902904 | negative regulation of supramolecular fiber organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006081 | cellular aldehyde metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0010639 | negative regulation of organelle organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0008290 | F-actin capping protein complex | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046677 | response to antibiotic | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0004618 | phosphoglycerate kinase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006189 | 'de novo' IMP biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006188 | IMP biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009073 | aromatic amino acid family biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009072 | aromatic amino acid family metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0004107 | chorismate synthase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0008108 | UDP-glucose:hexose-1-phosphate uridylyltransferase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0006206 | pyrimidine nucleobase metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:1901616 | organic hydroxy compound catabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0071545 | inositol phosphate catabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046855 | inositol phosphate dephosphorylation | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046838 | phosphorylated carbohydrate dephosphorylation | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046174 | polyol catabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046164 | alcohol catabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0046040 | IMP metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0045010 | actin nucleation | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0005885 | Arp2/3 protein complex | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0097435 | supramolecular fiber organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0051495 | positive regulation of cytoskeleton organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0044089 | positive regulation of cellular component biogenesis | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0032273 | positive regulation of protein polymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0031334 | positive regulation of protein-containing complex assembly | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0009166 | nucleotide catabolic process | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0005856 | cytoskeleton | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0007015 | actin filament organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0030837 | negative regulation of actin filament polymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:1902905 | positive regulation of supramolecular fiber organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0010638 | positive regulation of organelle organization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0030838 | positive regulation of actin filament polymerization | 0.67% (1/149) | 5.93 | 0.016404 | 0.046629 |
GO:0016740 | transferase activity | 6.04% (9/149) | 1.2 | 0.016757 | 0.046671 |
GO:0006793 | phosphorus metabolic process | 4.03% (6/149) | 1.55 | 0.016756 | 0.046986 |
GO:0006796 | phosphate-containing compound metabolic process | 4.03% (6/149) | 1.55 | 0.016756 | 0.046986 |
GO:0005488 | binding | 18.79% (28/149) | 0.58 | 0.01746 | 0.048307 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.38% (11/149) | 1.2 | 0.008304 | 0.049228 |
GO:0009058 | biosynthetic process | 6.04% (9/149) | 1.18 | 0.018028 | 0.049548 |